Celltrion Confirms EU Bevacizumab Filing

CT-P16 Biosimilar Rival To Avastin Has Been Submitted To The EMA

 
• By David Wallace
  
EMA
Celltrion has filed CT-P16 with the EMA

More from Biosimilars

More from Products